Tobias S. Pustjens

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: a Bayesian re-analysis of the SLIM trial.

Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: a Bayesian re-analysis of the SLIM trial.

Journal: American heart journal

Published: December 16, 2025

Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical Trial.

Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical Trial.

Journal: JAMA

Published: August 31, 2025

Myocardial infarction with nonobstructive coronary arteries - the European PERspective (SNIPER) survey.

Myocardial infarction with nonobstructive coronary arteries - the European PERspective (SNIPER) survey.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: April 16, 2025

Female- and age-specific reference values for blood pressure and its relationship with cardiac aberrations after pre-eclampsia.

Female- and age-specific reference values for blood pressure and its relationship with cardiac aberrations after pre-eclampsia.

Journal: European journal of preventive cardiology

Published: January 09, 2025

Female- and age-specific reference values for blood pressure and its relationship with cardiac aberrations after preeclampsia.

Female- and age-specific reference values for blood pressure and its relationship with cardiac aberrations after preeclampsia.

Journal: European journal of preventive cardiology

Published: January 09, 2025

Revascularisation in acute coronary syndromes: change in practice?

Revascularisation in acute coronary syndromes: change in practice?

Journal: Lancet (London, England)

Published: February 13, 2023

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome.

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome.

Journal: Journal of clinical medicine

Published: September 27, 2022

Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study.

Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study.

Journal: Frontiers in cardiovascular medicine

Published: April 30, 2022

Short-term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new-generation drug-eluting stent.

Short-term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new-generation drug-eluting stent.

Journal: Diabetes/metabolism research and reviews

Published: December 17, 2021

Unraveling the Multitude of Etiologies in Myocardial Infarction With Nonobstructive Coronary Arteries.

Unraveling the Multitude of Etiologies in Myocardial Infarction With Nonobstructive Coronary Arteries.

Journal: The American journal of cardiology

Published: October 26, 2021

Importance of confirming the underlying diagnosis in patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): a single-centre retrospective cohort study.

Importance of confirming the underlying diagnosis in patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): a single-centre retrospective cohort study.

Journal: BMC cardiovascular disorders

Published: March 05, 2021

Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.

Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: June 11, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026